Member Info for JohninGsy

Where did our friend get his cheap £3.50 warrants from. I have been in Hemo for several years and through the big dilutions but am not aware of any warrants. Did they come from the big dilution? Please let me know because I do not want to miss out !!! Thanks.

Guys - Whatever happened to the so called "deferred shares" which were calculated at the time of the consolidation. Are these dead and buried or is there any liklihood they may come back to everyday life. Just a thought but clinging onto straws possibly!!

HEMO recovering at long last. I need to see about £17 before I am breaking even. I used to have a small holding of 200,000 shares but the 400:1 consolidation caused me problems. Surely there should be some compensation offered to the original shareholders who supported the company to achieve survival simply because we believed in the project and respected the science and scientists behind the company at the time. We believed the company was close to financial failure but supported the few financings when requested. Obviously our beliefs were well founded but it would be good to get some recognition. On a different note my employer's fund used to own about 5% in a new US Pharma which we originally launched and funded. After a few years I was reluctantly persuaded to sell the shares by our advisors which I eventually carried out. I have since discovered that that same company was bought by Johnson & Johnson some 5 years later for USD4.2 billion and 5% of that transaction would have been worth the wait. Hindesight is a wonderful thing BUT will the same happen to HEMO in due course. I believe there is every possibility of a very positive outcome, maybe not at the levels previously mentioned so that is why I am still here because I believe in the science and understand the public need for such.

I have been a HEMO investor for many years simply because I was a Lymphoma patient and was very interested in Vlad's mission. I had an initial investment of 100,000 shares but these were consolidated in the 400:1 corporate action so my shareholding was almost wiped out. We are now beginning to see signs of life and progress in HEMO and I was wondering whether there was any route for compensation for the original investors who effectively kept the show on the road in the early days and should now be suitably rewarded. The current share price needs to recover to over £15 before I am breaking even so this situation seems very unfair to the original shareholders. Can anyone make any suggestions or give me a clue as to whether I can do anything about my problem.

Apologies - I have checked and you are correct we will be receiving deferred ordinaries. However normally Deferreds need a milestone for ultimate conversion presumably into ordinaries and I wondered what that milestone was. Logically the LTH should be compensated for providing venture capital on demand over several years to enable the company to live this long and develop its pipeline.

i will have to read the consolidation document again but i thought we were to receive new shares consolidated at 400:1 plus warrants and it was these warrants i was uncertain about. i will check that i have not misunderstood which is quite possible. warrants are normally convertible at some future milestone which would be good and appropriate recognition for the lth who have kept the faith in hemo over the years but have lost share value during the journey. some of us have shouldered a chunky loss to date.

a few years ago i argued with our investment advisors who wanted to sell a particular us biotech company which we had funded since its formation and we held about 5% of the company. the shares were reluctantly sold but under ten years later the same company was sold to johnson & johnson for usd4.2 billion !!! 5% of that would have given a very comfortable pension!! maybe **** will go the same way.

What does anybody think or know about what will happen with our warrants after consolidation. Will they become bits of paper for lighting the fire or will they hold any future value in the end. It doesn't mention whether they will be convertible or not. It is just academic interest at the moment because I have confidence in the science and the development work which appears to be right on target for zapping blood cancers as well as solid cancers in due course. Once this science is proven and recognised by the Big Pharma then there could easily be a very profitable takeover. Think positive and we will get there once we are rid of these immoral shorters after consolidation.

I am no biotechnologist even though I am just coming to the end of my apparently successful treatment of Non Hodgkin's Lymphoma which is a great relief for me having used the RCHOP chemo regime of treatment courtesy of the Southampton Hospital specialists. Anyway, we all know that the famous gold medal cyclist Chris Hoy has fairly recently been diagnosed with a critical and possibly terminal cancer and I wondered whether any of the Hemo work could help him. In particular I am thinking about the CAR-T development which is being expanded to cover solid cancers as well as blood cancers. I am sure that if this work gave any glimmer of hope for Chris he would be keen to take part in clinical trials even if they were US based. Just think of the PR for Hemo if this did end up helping Chris, such a high profile athlete but how do we start the process to check whether Chris is a potential candidate for clinical trials with the problem of medical confidentiality. Any ideas or am I just up the wrong tree in trying to help Chris??

If my memory serves me correctly AP (with his mining background) and the Chariot geologists did a tremendous amount of data collection in the years pre IPO in 2008 when they set up a brand new data room for Namibia. The IPO released funds to enable drilling in the Namibia basin but as you may recall the drill results were sadly zero. There were strong suggestions that the drill was done in the wrong place but I cannot recall what happened thereafter other that the share price took a major dive from £3 to pennies. However, sufficient to note that the Oil majors have since been very successful in that area so it is quite possible that AP and the Chariot geologists were correct in the first place and their data room will back up that evidence. Now, by revisiting Namibia it strongly suggests that the Chariot data is still showing potential resources still available and no doubt that Jimmy with his knowledge of such data will help to confirm that situation. I don't believe that Chariot will be drilling "in the dark" because they have a very long history of research in that area. At one stage the Namibia geology was compared to the offshore Brazil geology which was significantly oil rich in those days.

I hope the Chariot BOD are not chasing shadows in Namibia but if they are correct this could be a very important venture.

Thanks Haywain. I am no bio-chemist so I do not understand some of the technology and technical terms . However, I am a Non Hodgkins Lymphoma patient and so far have been successfully treated for the disease according to blood tests to date. I know about T cells because that was a main problem with my NHL. I identified with HEMO when I learned that Vlad was concentrating on Lymphomas due to his family histories.

In a previous life I was heavily involved with venture capital and concentrating on new technologies so had exposure to new drug pipelines mainly in the US , some very successful biotech companies as well as emerging computer technology companies - for example we were the very first investors in a new company called Apple Computer back in the mid-1970's. A colleague met the two Steves in the infamous home garage and agreed to buy an 8% interest with a guy named Valentine who was helping the Steves to raise initial capital for the new company. We sold the shares in the mid 1980's after Apple had been through a serious down swing in their business even though Jobs told us that they had some exciting new products in the pipeline !!! Hindsight is a wonderful thing !!.

I just "googled" New US Cancer Treatment and the FDA approvals website came up. The following is an extract of the most recent newsworthy approval:. It appears to be in a similar environment to our HEMO work.

Quote:

FDA grants accelerated approval to epcoritamab-bysp for relapsed or refractory follicular lymphoma On June 26, 2024, the Food and Drug Administration granted accelerated approval to epcoritamab-bysp (Epkinly, Genmab US, Inc.), a bispecific CD20-directed CD3 T-cell engager, for adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.

I have noted plenty of investment hype from American investment advisors about a new cancer drug which promises to revolutionise the treatment of cancers. Apparently it has received "fast track" FDA approval but I am unsure of how far it has progressed with the testing. I do not even know the name of the drug or the drug company simply because I have not subscribed to the investment advisors. I believe it is a US dug company.

Unless I am mistaken HEMO also has a revolutionary cancer drug with FDA testing approval but is it the same or similar to the "hype" mentioned. Perhaps Vlad needs the services of a US PR company in order to improve the HEMO image. Does anyone have any ideas as to the "Hyped" cancer drug and does it have any similarity to the efforts of the HEMO team which we have all been supporting for several years ? Any info most welcome.

At long last you have brought a line of discussion which is very well informed, positive and very intelligent in contrast to others on here. As I have mentioned before I have been involved with venture capital for many years from a financial investment perspective but without naming names we have been involved with cancer research drugs, mechanical heart valves, stem cell research and applications, alzheimers and parkinsons disease research, anti arrhythmia drug development as well as viagra. Some projects were more successful than others but in every case we were 100% behind the drug development exercise and supported project throughout. Hemo has a brilliant team of scientists, good facilities and a very capable management team but I do know that dealing with the American FDA can be a challenge. In the past I have seen knighthoods awarded to some of our more successful scientists which is a great endorsement for their efforts. As I have said before I have a personal medical interest in the success of Hemo as well as a financial interest and hopefully we can all support Vlad and his team in the expectation of a successful medical and financial outcome. I am not sure how you can short sell a medical outcome rather than a financial outcome!! Patience is a virtue but it usually pays off provided your research into the project and the company personalities has been reliable.

As an aside, our company (not me) were the first venture capital investors into the original Apple Computer back in the 1970's and yes, we did make a few pennies profit when we sold but it is mind blowing to consider what our original 8% would have been worth in todays market. Hopefully HEMO can follow suit but on a shorter timeframe. Keep the Faith !!!

Just out of interest my background was in Hi tech venture capital, particularly in the US market. We usually invested right at the beginning of new ventures normally via convertible pref shares. One biotech that I do recall where we held approx 5% of the equity. The company made good progress with their drug development programme, went to a successful IPO and unfortunately our Board decided to sell even though I voted against the sell decision. Yes, we did make a few million on the sale but nine years later that same company was sold to Johnson and Johnson for 4.2 billion dollars!! A 5% interest in that sale would have been quite worthwhile.

Four years ago I was diagnosed with Non Hodgkins Lymphoma (NHL) and by absolute co-incidence I came across Hemogenyx and saw that our friend Vlad was strongly focussed on NHL so I became a reasonably significant LTH in the belief that one day I may need Vlad's drugs. In the meantime I have been treated and am now very pleased to be "in remission". In any case it would be wonderful if HEMO was to develop and eventually be purchased by Big Pharma on similar terms to that mentioned earlier!

I have also been involved with Phase 1 and Phase 2 clinical trials from a business point of view. but in the UK. These trials are very strict particularly Phase 1 which is "first into Man" and if there is any doubt as to the drug safety it will be failed and referred back to the developer. However, if it survives Phases 1 and 2 the future prospects are very much improved. All this does take time with an incredible amount of formal paper work and certifications but eventually the payback can be unbelievable. HEMO have at least three big drug developments in progress so the future does look very positive indeed for the company and Vlad does have some excellent people around him who know the biotech world.

Patience is a virtue and that is why I have not ordered a new Aston Martin as yet but hopefully my NHL will not cause a future problem and I will be able to enjoy the Aston in a few years time!!

Keep the Faith and ignore the shorters who should be banned from these important shares. I am sure I am in the right place at this time as a LTH.

Jimmy. Please include me as well; "JohninGsy". How do I access the Group because I am interested in joining. I have been a LTH for many years and have known AP personally for many years as well so I want to keep in touch with Chariot developments.

I really value your contributions to this site. They bring a reality rather than some of the comedians / rampers that we see with some of the banter on here.

Troajan - Having checked your link you must be very wary of their comments and information. The article author reckoned that Pouroulis joined Chariot in 2020. What a load of rubbish. We all know that AP founded the company in the early 2000's and took it to an IPO sometime thereafter when Chariot had identified Oil potential offshore Namibia. My advice is not to take too much notice of these uninformed contributors.

Thanks JHFH for the very useful update and history lesson. I have been a LTH since 2020 when I was diagnosed with Non Hodgkins Lymphoma, stage 4. At that time I was starting chemo therapy and quite by chance found that Vlad was trying to develop drugs to combat NHL and blood cancers largely due to his family medical history. My professional background is in venture capital when I was based in Bermuda so I took Vlad at his word and purchased a reasonable number of shares in the belief that Eli Lilly were virtually in bed with Vlad. Unfortunately the SP took a gradual dive thereafter for whatever reason but I have hung on in the belief that Vlad will prevail and I may need his drugs in the future. Fortunately my chemo has been successful so far and I am in remission but there is always the possibility of a relapse. Therefore it is clear that I am invested in Hemo both for personal medical reasons and also hopefully for significant financial profit regardless of the dubious activities of some of the traders and brokers around here.

Over the years I have been involved with some unbelievably successful world famous technology and biotech companies where we invested at a very early stage usually as a private company prior to IPO as well as a few failures which I am not going to disclose here but this does make me very aware of the tremendous potential of each of Vlad's pharma pipelines. Hopefully Vlad will see good sense and will stop playing finance games with the less scrupulous brigade mentioned by JHFH in the hope of saving a few pennies and he will start to use industry professionals with a solid track record for the ultimate benefit of all involved here. The FDA approvals for clinical trials should be a watershed and thereafter any new corporate partners will expect to deal with top grade professionals not cowboys. It would be very positive if Vlad and his BOD would share more information via RNS communications and would stop relying of social media gossip.

We need to clear Phase one and Phase two clinical trials and if they are successful we should see some very significant revaluations.

We hope for the best.

I have been a LTH in CHAR for many, many years and anyone who has been involved in the investment industry will know that late July and August are essentially dead periods for investment information. Once the schools go back in early September life resumes and sometime thereafter news should begin to flow. I am sure that Adonis and his family will be away on holiday as will be many of his core staff so unfortunately we all have to wait for everyone to get back to their desks sometime after the US Labour Day.

Hopefully the wait will be worthwhile this year and a bit more productive than previous years.

Thank you Jimmy for your continual flow of very useful and informative industry information over the years. Hopefully we will all get to pay day in the near future.

Unfortunately I have to agree with the comments on RSA. Confirmation IMO is when the Russians and Chinese are having meetings or arranging visits to Southern Africa because they are fully aware of the natural resources available in RSA and neighbouring countries so it is only a matter of time before they step in to assist. I lived in RSA for four years and it is/ was a wonderful country with massive potential. Gold, diamonds, platinum, coal and now rare earths make for a valuable collection of resources.

I have been with this ridiculous company for too many years to remember and during that time the directors and senior executives have continued taking eye watering bonuses for essentially driving the company into the ground. Surely the real shareholders should have some rights to compensation for serious mismanagement and unbelievably stupid name changes!!